In described cases of renal disease due to CD2AP variants, the age of onset is generally quite young (ages 2–21 [187]), and it is possible that with prolonged follow-up these individuals may eventually develop pathology consistent with AD. The gene discussed is CD2AP; the disease is Alzheimer disease.